2.02Open2.02Pre Close0 Volume2 Open Interest82.00Strike Price0.00Turnover64.89%IV-1.33%PremiumDec 13, 2024Expiry Date3.07Intrinsic Value100Multiplier1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8985Delta0.0764Gamma24.86Leverage Ratio-0.2599Theta-0.0013Rho-22.34Eff Leverage0.0064Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet